Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th Ed.) Cambridge University Press. Chapter 7, “Treatments for Mood

Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th Ed.) Cambridge University Press.

Chapter 7, “Treatments for Mood Disorders: So-Called “Antidepressants” and “Mood Stabilizers” (pp. 338-358)

American Psychiatric Association. (2010b). Practice guideline for the treatment of patients with bipolar disorderLinks to an external site. (2nd ed.)https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/bipolar.pdfChen, R., Wang, H., Shi, J., Shen, K., & Hu, P. (2015). Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: Comparison of traditional phenotype and activity score systems. European Journal of Clinical PharmacologyLinks to an external site., 71(7), 835–841. https://doi.org/10.1007/s00228-015-1855-6Hirschfeld, R. M. A. (n.d.). Guideline watch: Practice guideline for the treatment of patients with bipolar disorderLinks to an external site. (2nd ed.).  https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/bipolar-watch.pdfVitiello, B. (2013). How effective are the current treatments for children diagnosed with manic/mixed bipolar disorder? CNS DrugsLinks to an external site., 27(5), 331–333. https://doi.org/10.1007/s40263-013-0060-3